Concepedia

Sharon Webster

SW

Statistics

Publications

7

Citations

515

H-Index

7

Active since

2007

Affiliations

National Institutes of Health(Current)

National Institute of Allergy and Infectious Diseases

Erasmus MC

Charles University

Frederick National Laboratory for Cancer Research

Sharon Webster is an author at National Institutes of Health specializing in pi3k signaling, phosphoinositide 3-kinase signaling, and medicine.

Publications per year

2007–2024

7

Publications

7

Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib

V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm et al. · Blood · 2017 · 286 citations · Full text

, , +10

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

V. Koneti Rao, Sharon Webster, Anna Šedivá et al. · Blood · 2022 · 132 citations · Full text

, , +13

Interim analysis: Open-label extension study of leniolisib for patients with APDS

V. Koneti Rao, Elaine Kulm, Anna Šedivá et al. · Journal of Allergy and Clinical Immunology · 2023 · 40 citations · Full text

, , +15

Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome

V. Koneti Rao, Elaine Kulm, Jennifer Grossman et al. · Blood Advances · 2024 · 15 citations · Full text

, , +14

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

V. Koneti Rao, Anna Šedivá, Virgil A. S. H. Dalm et al. · Clinical Immunology · 2024 · 15 citations · Full text

, , +15

1–5 of 7